COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

Remission Foundation Inc

RYE BROOK, NY · EIN 452752633 · Form 990 · FY2025 · NTEE P123 · Human Services · Small ($100K-$1M) · remissionfoundation.org
revenue
$154K
expenses
$150K
net assets
$16K
employees
0
volunteers
10
program ratio
0%
mission · from form 990

ReMission Foundation has been a dedicated advocate for investing in cancer research since 2011. We support innovative cancer treatment developments and partner with smaller causes to amplify their impact. By providing financial assistance and resources we help reduce research costs and enable fundraising efforts to promote their missions to broader communities. Together we can drive change and support breakthroughs in cancer research.

profile · synthesized from sources

ReMission Foundation is a nonprofit that supports innovative cancer research by funding specific researchers and causes annually. Since 2011, it has focused on amplifying impact through targeted fundraising, primarily via events like its annual charity golf tournament and helicopter ball drop. All proceeds from each year’s campaigns are directed to a single designated recipient or research initiative.

named programs · 3 · from sources

What they call their work

Annual Cause Initiative
Yearly program directing all fundraising proceeds to a single researcher or organization, such as Dr. Darren Feldman's work on germ cell tumors or pancreatic cancer screening awareness
Annual Charity Golf Tournament
16th annual golf event held at Paramount Country Club to raise funds for a selected cancer research cause, featuring sponsorships, hole challenges, and donor recognition
Helicopter Ball Drop
Event launching the annual golf outing where numbered golf balls are dropped by helicopter; donors win a portion of proceeds based on proximity to target
activities · 3 groups

What they do

  • Biomedical Research and Innovation 1 activity
    • Developing and validating novel cancer diagnostic assays
      Conducted research to develop blood-based tumor marker tests using microRNA 371a-3p and microRNA 372-3p to monitor germ cell tumor disease status in patients with non-elevated traditional markers, and secured New York State Department of Health approval for the MSK MicroRNA Assay (MMA), the first such approval in the United States.
  • Cancer Research Funding 1 activity
    • Funding cancer research for specific investigators and projects
      Provides grants to support individual researchers and targeted cancer research initiatives, including Dr. Darren Feldman's work on germ cell tumors and testicular cancer at Memorial Sloan Kettering Cancer Center, Dr. Alana Nguyen's research on anti-tumor immunity in peritoneal metastatic cancer, and the pancreatic cancer screening awareness campaign led by Drs. Charles M. Noyer and Joshua Raff. All proceeds from annual fundraising are directed to a single selected researcher, organization, or cause each year.
  • Charity Golf Tournament Fundraiser 1 activity
    • Organizing annual charity golf tournament and associated events
      Hosts the 16th Annual Charity Golf Outing, supported by sponsorship tiers offering branding and advertising benefits, and includes a Helicopter Ball Drop event as a launch activity. The event aims to raise $40,000 through the sale of up to 2,000 donated golf balls at $20 each.
financials · form 990 · fy2025
revenue
Total revenue$154K
Contributions & grants$81K53%
Program service revenue$00%
Investment income$00%
Other revenue$73K
expenses
Total expenses$150K
Program expenses0%
Admin / overhead0%
Fundraising0%
Salaries & benefits$0
Grants paid out$150K
Largest expense lineCompensation
balance sheet
Total assets$166K
Cash$166K
Investments$0
Liabilities$150K
Net assets$16K
Liquid reserves13.3 mo
5 years on record · 2021–2025 · YoY revenue +12.6%
leadership · form 990 part vii · fy2025

Who runs it

board members · 4
  • Adam Landsman — Board Member
  • David Crystal — Board Member
  • David Yaches — Board Member
  • Michael Beckerman — Board Member
relationships · 10

Who they work with

  • FOXTROT Partner — Partner organization collaborating with ReMission Foundation on the Helicopter Ball Drop event.
  • Memorial Sloan Kettering Cancer Center Partner — Collaborates on the development and clinical application of microRNA assays for germ cell tumors.
  • Memorial Sloan Kettering Cancer Center Partner — Collaborates with MSK through funding of Dr. Darren Feldman's research on testicular cancer.
  • Memorial Sloan Kettering Cancer Center Partner — Collaborates with MSK to support research for germ cell tumors and testicular cancer led by Dr. Darren Feldman.
  • Memorial Sloan Kettering Cancer Center Partner — Collaborates with ReMission Foundation to support research on germ cell tumors and testicular cancer.
  • Paramount Country Club Partner — Hosts the annual ReMission Foundation charity golf tournament.
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital Partner — Collaborates with ReMission Foundation in supporting research on peritoneal metastatic cancer.
  • White Plains Hospital Cancer Center Partner — Collaborates with ReMission Foundation to support the Pancreatic Cancer Screening Awareness Campaign.
  • smaller causes Partner — Partners with smaller causes to amplify their impact through financial assistance and resource sharing.
  • smaller causes Partner — Partners with smaller organizations to amplify their impact in cancer research.
strategies · 5

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Cancer Biology–Driven Therapy Development
    methodology: cancer-biology-driven-therapy-development
    By leveraging deep expertise in cancer biology and genetics, we develop novel therapies for advanced germ cell tumors, because targeting the molecular basis of disease enables more effective and precise interventions.
  • Event-Based Fundraising to Sustain Research Philanthropy
    methodology: event-based_fundraising
    By hosting high-engagement charity events with tiered sponsorships, we generate reliable funding and public visibility for testicular cancer research, because experiential fundraising deepens donor connection and incentivizes sustained participation through branding and engagement benefits.
  • Focused Grantmaking to Maximize Research Impact
    methodology: focused_grantmaking
    By concentrating fundraising proceeds on a single researcher, organization, or cause annually, we achieve greater impact through sustained and targeted support, because focused funding reduces fragmentation and increases the likelihood of measurable progress in specialized cancer research.
  • MicroRNA Biomarker Development Across the Care Continuum
    methodology: multi-application-biomarker-development
    By developing microRNA-based assays, we enable earlier diagnosis, better treatment monitoring, and improved surgical and surveillance decisions, because molecular biomarkers provide real-time biological insights that enhance clinical decision-making at multiple stages of cancer care.
  • Supporting Ingenuity in Cancer Research Through Targeted Funding
    methodology: supporting_ingenuity_in_research
    By funding innovative and unconventional approaches in cancer research, we accelerate breakthroughs in underexplored areas, because high-potential ideas outside mainstream paradigms often lead to transformative advances when given early support.